• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of CDRH intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Information is current as of September 30, 2013

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetPercent
Oct 20108588
Nov 20108587
Dec 20108588
Jan 20118587
Feb 20118588
Mar 20118589
Apr 20118591
May 20118588
Jun 20118589
Jul 20118588
Aug 20118588
Sep 20118588

FY 2011 Overall: 88%

Number of CDRH intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A1,276
Nov 2010N/A1,380
Dec 2010N/A1,283
Jan 2011N/A1,374
Feb 2011N/A1,282
Mar 2011N/A1,774
Apr 2011N/A1,545
May 2011N/A1,575
Jun 2011N/A1,820
Jul 2011N/A1,395
Aug 2011N/A1,646
Sep 2011N/A1,445

FY 2011 Total: 17,795

Total number of CDRH intra- and inter-Office eConsults completed during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A1,452
Nov 2010N/A1,584
Dec 2010N/A1,463
Jan 2011N/A1,576
Feb 2011N/A1,460
Mar 2011N/A2,004
Apr 2011N/A1,704
May 2011N/A1,790
Jun 2011N/A2,049
Jul 2011N/A1,582
Aug 2011N/A1,860
Sep 2011N/A1,649

FY 2011 Total: 20,173

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.